Nobutaka Nishimura
Papers
1
Total Citations
4
H-Index
1
About
Dr. Nobutaka Nishimura is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for patients with localized prostate cancer, particularly through the refinement of robot-assisted radical prostatectomy (RARP) techniques. His major contributions center on the clinical significance of pelvic lymph node dissection (PLND), where he has systematically compared the diagnostic and therapeutic benefits of limited versus extended lymph node removal. In his landmark 2022 propensity score-matched study, Dr. Nishimura demonstrated that extended PLND significantly improves the detection of lymph node metastases (pN1) without a corresponding increase in biochemical recurrence rates, providing critical evidence for surgical decision-making. This work has garnered attention within the urology community, accumulating citations that underscore its clinical relevance. Dr. Nishimura’s research bridges the gap between surgical precision and oncologic efficacy, offering urologists data-driven guidance on balancing the risks and benefits of lymph node dissection. His findings are particularly valuable for surgeons seeking to maximize diagnostic accuracy while minimizing overtreatment, establishing him as a thoughtful contributor to the evolution of minimally invasive prostate cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1